CADIAN CAPITAL MANAGEMENT, LP

Position in BSX — Boston Scientific Corp

CIK 1423686 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,667,500

New position

Shares Held

170,000

first reported quarter

Ownership

0.011%

of shares outstanding

% of Portfolio

1.30%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CADIAN CAPITAL MANAGEMENT, LP holds $62,920,710 across 4 Medical Devices names. BSX ranks #3 (17.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TCMD	Tactile Systems Technology Inc	1,041,072	$27,203,211
2	SIBN	SI-BONE, Inc.	1,887,472	$23,838,771
3	BSX	Boston Scientific Corp This page	170,000	$10,667,500
4	MXCT	Maxcyte, Inc.	1,722,942	$1,211,228

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,667,500	170,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.